DaxibotulinumtoxinA

Global equities rebounded in 3Q24, with health care stocks advancing in July and August, then falling in September. Biotechnology stocks led the sector, driven by factors like interest in innovative weight-loss drugs, easing supply constraints, increased health care utilization, and the sector's defensive nature. Key contributors included Applied Therapeutics, ARS Pharmaceuticals, and Revance Therapeutics. The fund's performance was aided by favorable stock selection, particularly in biotechnology, while detractors included HilleVax and Guardant Health. The outlook remains positive for biotechnology, supported by strong fundamentals, innovation, and M&A activity, despite risks from inflation and the IRA drug pricing measures.

Serotonin Centers launches new St. Petersburg location offering personalized wellness solutions, including aesthetic enhancement, hormone balancing, weight loss, and muscle development.

AbbVie lost $40 billion in market value after its experimental drug emraclidine failed two clinical trials for schizophrenia. Despite the setback, AbbVie remains focused on neuroscience and has a diverse portfolio of brain medicines. The failure of emraclidine removes a competitive threat for Bristol Myers' Cobenfy, an approved antipsychotic.

Javascript not activated

Botox Cosmetic's FDA approval for platysma bands may increase awareness and patient inquiries, offering a nonsurgical solution for vertical jaw-neck bands.

FDA publishes 'Catching Up with Califf: One Health' by Commissioner Robert M. Califf, updates 2022 Food Code, announces first pre-harvest agricultural water treatment, authorizes LumiThera's Valeda Light Delivery System for dry AMD, and arrests Massachusetts spa owner Rebecca Fadanelli for illegal injections.

Rebecca Fadanelli allegedly performed thousands of fake injections at her beauty clinic without a license, using counterfeit drugs from China. She made $900,000 and was pursued by FDA and Homeland Security.

Massachusetts woman Rebecca Fadanelli, 38, accused of performing thousands of illegal counterfeit Botox and filler injections over three years at Skin Beaute Med Spa. Fadanelli, posing as a nurse, imported products from China and Brazil, earning over $900,000. She faces up to 20 years in prison and fines for importing and selling counterfeit drugs.

Rebecca Fadanelli, 38, arrested for allegedly performing thousands of illegal counterfeit Botox and filler injections since 2021 at spas in Easton and Randolph, Massachusetts.

FDA approved Botox Cosmetic for improving moderate to severe platysma bands, marking its fourth aesthetic indication. It offers a nonsurgical, injectable solution for adults, with doses of 26, 31, or 36 units based on severity. Clinical trials showed significant satisfaction among patients. Allergan Aesthetics promotes education and rewards through its Allē program.